Cargando…

Newly diagnosed exudative age-related macular degeneration treated with pegaptanib sodium monotherapy in US community-based practices: medical chart review study

BACKGROUND: Studies have shown that early detection and treatment of neovascular age-related macular degeneration (NV-AMD) can delay vision loss and blindness. The objective of this study was to evaluate the efficacy/safety of intravitreal pegaptanib sodium monotherapy in treatment-naïve subjects wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weber, Pamela A, Wirostko, Barbara M, Xu, Xiao, Goss, Thomas F, Zlateva, Gergana
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2836307/ https://www.ncbi.nlm.nih.gov/pubmed/20144224 http://dx.doi.org/10.1186/1471-2415-10-2

Ejemplares similares

Effect of Switching Therapy to Pegaptanib in Eyes With the Persistent Cases of Exudative Age-Related Macular Degeneration
por: Shiragami, Chieko, et al.
Publicado: (2014)

Role of pegaptanib sodium in the treatment of neovascular age-related macular degeneration
por: Sivaprasad, Sobha
Publicado: (2008)

Pegaptanib Sodium versus Pegaptanib Sodium Combined with Macular Laser Photocoagulation or Laser Alone for Diabetic Macular Edema
por: Querques, G., et al.
Publicado: (2009)

Comparison of the effect between pegaptanib and ranibizumab on exudative age-related macular degeneration with small lesion size
por: Nishimura, Yoshihiro, et al.
Publicado: (2012)

Pegaptanib sodium for neovascular age-related macular degeneration: clinical experience in the UK
por: Sivaprasad, Sobha, et al.
Publicado: (2008)

Pegaptanib in the treatment of wet, age-related macular degeneration
por: Vinores, Stanley A
Publicado: (2006)

Pegaptanib sodium as maintenance therapy in neovascular age-related macular degeneration: the LEVEL study
por: Friberg, Thomas R, et al.
Publicado: (2010)

Pegaptanib sodium treatment in neovascular age-related macular degeneration: clinical experience in Germany
por: Feucht, Nikolaus, et al.
Publicado: (2008)

Clinical experience with pegaptanib sodium
por: Rosina, Chiara, et al.
Publicado: (2008)

Population pharmacokinetics of pegaptanib sodium (Macugen(®)) in patients with diabetic macular edema
por: Basile, Anthony S, et al.
Publicado: (2015)

Pegaptanib sodium for ocular vascular disease
por: Shukla, Dhananjay, et al.
Publicado: (2007)

Intravitreal pegaptanib for the treatment of ischemic diabetic macular edema
por: Kiire, Christine A, et al.
Publicado: (2015)

A retrospective, pooled data analysis of the safety of pegaptanib sodium in the treatment of age-related macular degeneration in subjects with or without diabetes mellitus
por: Dombi, Theresa, et al.
Publicado: (2012)

Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial
por: Singerman, L J, et al.
Publicado: (2008)

The importance of pegaptanib sodium treatment for patients with vascular active vitreoretinopathy
por: Zhang, Rui, et al.
Publicado: (2017)

Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion
por: Udaondo, Patricia, et al.
Publicado: (2011)

Five-Year Outcome of Aflibercept Monotherapy for Exudative Age-Related Macular Degeneration with Good Baseline Visual Acuity
por: Kikushima, Wataru, et al.
Publicado: (2021)

An open-label, one-year, noncomparative study to evaluate the safety and tolerability of intravitreal pegaptanib sodium in patients with diabetic macular edema
por: Sivaprasad, Sobha, et al.
Publicado: (2014)

Two-year outcomes of pro re nata ranibizumab monotherapy for exudative age-related macular degeneration in Japanese patients
por: Yamamoto, Akiko, et al.
Publicado: (2013)

Therapeutic Modalities of Exudative Age-related Macular Degeneration
por: Mavija, Milka, et al.
Publicado: (2014)

Intravitreal sirolimus with adjunct aflibercept versus aflibercept monotherapy for persistent, exudative age-related macular degeneration: a pilot study
por: Rowe, Lucas W., et al.
Publicado: (2023)

Early Signs of Exudative Age-Related Macular Degeneration in Asians
por: Sasaki, Mariko, et al.
Publicado: (2014)

Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept
por: García-Layana, Alfredo, et al.
Publicado: (2015)

Unusual visual loss in a patient with exudative macular degeneration
por: Peng, Enoch T., et al.
Publicado: (2022)

Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis
por: Chakravarthy, Usha, et al.
Publicado: (2010)

Long-lasting effects of anti-VEGF/photodynamic combination therapy in the treatment of exudative age-related macular degeneration: a retrospective chart review
por: Silva-Garcia, Rosemary, et al.
Publicado: (2014)

Optical Coherence Tomography-Based Deep-Learning Models for Classifying Normal and Age-Related Macular Degeneration and Exudative and Non-Exudative Age-Related Macular Degeneration Changes
por: Motozawa, Naohiro, et al.
Publicado: (2019)

Age-related macular degeneration and the aging eye
por: Ehrlich, Rita, et al.
Publicado: (2008)

The Past, Present, and Future of Exudative Age-Related Macular Degeneration Treatment
por: Barak, Yoreh, et al.
Publicado: (2012)

Proteomics of Vitreous Humor of Patients with Exudative Age-Related Macular Degeneration
por: Koss, Michael Janusz, et al.
Publicado: (2014)

High-Density Lipoprotein Function in Exudative Age-Related Macular Degeneration
por: Pertl, Laura, et al.
Publicado: (2016)

Real-Life Data of Patients with Exudative Age-Related Macular Degeneration
por: Togac, Mesut, et al.
Publicado: (2021)

Joint Assessment of Intended and Unintended Effects of Medications: An Example Using Vascular Endothelial Growth Factor Inhibitors for Neovascular Age-Related Macular Degeneration
por: Levy, Adrian R., et al.
Publicado: (2009)

The Comparative Economic Burden of Mild, Moderate, and Severe Fibromyalgia: Results from a Retrospective Chart Review and Cross-Sectional Survey of Working-Age U.S. Adults
por: Chandran, Arthi, et al.
Publicado: (2012)

Unilateral macular exudation
por: Khanum, Aayesha, et al.
Publicado: (2021)

Clinical Wide-Field Retinal Image Deep Learning Classification of Exudative and Non-Exudative Age-Related Macular Degeneration
por: Tak, Nathaniel, et al.
Publicado: (2021)

Endothelin-1 and Nitric Oxide Levels in Exudative Age-Related Macular Degeneration
por: Totan, Yϋksel, et al.
Publicado: (2015)

Clinical and genetic characteristics of pachydrusen in patients with exudative age-related macular degeneration
por: Fukuda, Yoshiko, et al.
Publicado: (2019)

Correction: High-Density Lipoprotein Function in Exudative Age-Related Macular Degeneration
por: Pertl, Laura, et al.
Publicado: (2016)

Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab
por: Hamid, Mohamed A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ka9chqi4aa7155ogmvg2ho1ahq